Tous Actualités
Suivre
Abonner Boehringer Ingelheim

Boehringer Ingelheim

Personalising Cancer Care - An Invitation

Ingelheim, Germany, November 5 (ots/PRNewswire)

- For Non-US Healthcare Media
Can the quest for personalised medicine in cancer therapy ever be
realised? And how far have we come in the journey to personalised
cancer care?
What lies ahead from a clinical research perspective will be
discussed in an international media webcast entitled "Probable or
pipedream: could new cancer targets change the outlook for
personalised medicine?", in conjunction with the Multi-disciplinary
Symposium in Thoracic Oncology.
Eminent experts in the field, including Dr Nasser Hanna, Dr Paul
Bunn and Dr Vera Hirsh will discuss and debate future directions in
the process of cancer drug development and how the oncology community
is working to discover more intelligent and innovative treatment
solutions for the individual cancer patient.
Available online from 17 November 2008
To register please click the link below
http://www.personalisingcancercare.com
If you have difficulties registering please contact:
    Joy Burgess
    Ogilvy Healthworld
    Tel: +44(0)207-108-6519
    Tel: +44(0)7843098437
    Email:  joy.burgess@ogilvyhealthworld.com

Contact:

Joy Burgess, Ogilvy Healthworld, Tel: +44(0)207-108-6519, Tel:
+44(0)7843098437, Email: joy.burgess@ogilvyhealthworld.com

Plus de actualités: Boehringer Ingelheim
Plus de actualités: Boehringer Ingelheim